Get started
Hoth Therapeutics, Inc.Hoth Therapeutics, Inc.Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

HOTH chart


Full chart

HOTH upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪6.19 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.6918 USD
Net income (FY)
‪−7.85 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪6.84 M‬
Beta (1Y)
−0.40

Employees


Employees (FY)
6
Change (1Y)
+2 +50.00%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.31 M‬ USD

About Hoth Therapeutics, Inc.


Sector
Health Technology
CEO
Robbie Knie
Headquarters
New York
Website
hoththerapeutics.com
Founded
2017
FIGI
BBG00H0HZ8S8
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

HOTH news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of HOTH is 0.8970 USD — it has increased by 1.82% in the past 24 hours. Watch Hoth Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Hoth Therapeutics, Inc. stocks are traded under the ticker HOTH.
HOTH stock has risen by 5.53% compared to the previous week, the month change is a 10.74% rise, over the last year Hoth Therapeutics, Inc. has showed a −25.87% decrease.
We've gathered analysts' opinions on Hoth Therapeutics, Inc. future price: according to them, HOTH price has a max estimate of 5.00 USD and a min estimate of 3.00 USD. Watch HOTH chart and read a more detailed Hoth Therapeutics, Inc. stock forecast: see what analysts think of Hoth Therapeutics, Inc. and suggest that you do with its stocks.
HOTH reached its all-time high on Feb 19, 2019 with the price of 347.0000 USD, and its all-time low was 0.5800 USD and was reached on Aug 8, 2024. View more price dynamics on HOTH chart.
See other stocks reaching their highest and lowest prices.
HOTH stock is 6.07% volatile and has beta coefficient of −0.40. Track Hoth Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Hoth Therapeutics, Inc. there?
Today Hoth Therapeutics, Inc. has the market capitalization of ‪6.19 M‬, it has increased by 6.77% over the last week.
Yes, you can track Hoth Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Hoth Therapeutics, Inc. is going to release the next earnings report on Nov 27, 2024. Keep track of upcoming events with our Earnings Calendar.
HOTH earnings for the last quarter are −0.24 USD per share, whereas the estimation was −0.24 USD resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.24 USD per share. See more details about Hoth Therapeutics, Inc. earnings.
Hoth Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
HOTH net income for the last quarter is ‪−1.63 M‬ USD, while the quarter before that showed ‪−2.04 M‬ USD of net income which accounts for 20.01% change. Track more Hoth Therapeutics, Inc. financial stats to get the full picture.
No, HOTH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 6.00 employees. See our rating of the largest employees — is Hoth Therapeutics, Inc. on this list?
Like other stocks, HOTH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hoth Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hoth Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hoth Therapeutics, Inc. stock shows the sell signal. See more of Hoth Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.